PL
 |
EN
Nowa wersja platformy, zawierająca wyłącznie zasoby pełnotekstowe, jest już dostępna.
Przejdź na https://bibliotekanauki.pl
Ograniczanie wyników
Czasopisma help
  1. 6 Folia Histochemica et Cytobiologica
  2. 4 Journal of Physiology and Pharmacology
  3. 2 Journal of Physiology and Pharmacology. Supplement
  4. 1 Annals of Agricultural and Environmental Medicine
  5. 1 Baltic Journal of Health and Physical Activity. The Journal of Gdansk University of Physical Education and Sport
Więcej...
Lata help
  1. 1 2019
  2. 1 2017
  3. 1 2015
  4. 3 2011
  5. 3 2010
Więcej...
Autorzy help
  1. 2 Brodowska A.
  2. 2 Chojnacki C.
  3. 2 Chojnacki J.
  4. 2 Laszczynska M.
  5. 2 Starczewski A.
Więcej...
Preferencje help
Polish version English version Język
Widoczny [Schowaj] Abstrakt
Liczba wyników

Znaleziono wyników: 16

Liczba wyników na stronie
first rewind previous Strona / 1 next fast forward last
Wyniki wyszukiwania
Wyszukiwano:
w słowach kluczowych:  postmenopausal woman
help Sortuj według:

help Ogranicz wyniki do:
first rewind previous Strona / 1 next fast forward last
1
Association between gait speed and muscle mass and strength in postmenopausal women
100%
Ossowski Z. M. , Wiech M. , Ellwart M.
Baltic Journal of Health and Physical Activity. The Journal of Gdansk University of Physical Education and Sport
|
2019
|
tom 11
|
nr 1
2
Content available remote Mechanisms of circumduction and axial rotation of the carpometacarpal joint of the thumb
100%
Dumont C. , Perplies R. , Doerner J. , Fanghanel J. , Kubein-Meesenburg D. , Wachowski M. M. , Nagerl H.
|
|
tom 60
|
nr 8
65-68
3
Expression of estrogen receptors in the pelvic floor of pre- and post-menopausal women presenting pelvic organ prolapse
84%
Zbucka-Kretowska M. , Marcus-Braun N. , Eboue C. , Abeguile G. , Wolczynski S. , Kottler M. L. , Von Theobald P.
Folia Histochemica et Cytobiologica
|
2011
|
tom 49
|
nr 3
4
Content available Assessment of the influence of fluoride, modified transdermal replacement hormone therapy and supplement hormone therapy on unmanageable osteoporosis in postmenopausal women
84%
Stanosz M. , Stanosz S. , Puchalski A.
Journal of Elementology
|
2009
|
tom 14
|
nr 3
545-551
EN
The study was conducted on 40 women in the early postmenopausal period, aged 52.3±3.1 years with primary osteoporosis unmanageable in treatment, divided into 2 groups based on a randomized list. Group I (n-20) was administered orally fluoride 0.25 mg kg-1 24 h-1 with modified transdermal hormone therapy/HRT, and group II (n-20) was administered orally fluoride and supplement hormonal therapy(HST) in 21 therapeutic cycle. The serum concentrations of osteocalcin (OC), procollagen(PICP), insulin-like growth factor I (IGF-1), prolactin basic (PRL) and prolactin after metoclopramide (PRL/ MCP) 4 times by using radioimmunoassy methods, before treatment and after 1, 3, 12 months of treatment. Bone mineral density (BMD) L2 – L4 was determined before treatment and at 12 month with a dualenergy x-ray absorptiometry scanner (Lunar DPX-1Q). In group I women receiving fluoride and transdermal HRT IGF-1 increased significantly while the concentrations of OC and PICP significantly decreased after 3 and 12 months of treatment but no statistically significant changes in the PRL concentration occurred. In group II women receiving orally fluoride and HST, a significant decrease in the concentration of IGF-1, OC after 3 and 12 months and a significant increase in the concentration of PRL and PRL/ MCP after 1, 3 and 12 months of treatment compared with the baseline values appeared. The concentration of type I procolagen (PICP) showed no statistically significant changes. Increase in bone mineral density was statistically significant L1, L2 (p < 0.05), L3, L4 (p < 0.01) compared with the baseline in the group receiving transdermal HRT. In women receiving fluoride and orally HST increase in the bone mineral density for L1 and L2 was non-insignificant, whereas for L3 and L4 it was significantly higher compared with the baseline (p < 0.05).
PL
Badaniem objęto 40 kobiet we wczesnym okresie pomenopauzalnym, w wieku 52,3±3,1 lat, podzielonych wg listy randomizowanej na dwie grupy: grupę I. (n-20) otrzymującą doustnie fluor w dawce 0,25 mg kg-1 24 h-1 oraz zmodyfikowaną przezskórną hormonoterapię zastępczą (HTZ), grupę II (n-20) otrzymującą doustnie fluor w dawce 0,25 mg kg-1 24 h-1 i hormonoterapię wspomaganą (HTW) w postaci tabletek. Cykle terapeutyczne w obu grupach trwały 21 dni w miesiącu z następową przerwą 7 dni w celu wystąpienia krwawienia z odstawienia przez okres jednego roku. W surowicy oceniano stężenia osteokalcyny (OC), prokolagenu (PICP), insulinopodobnego czynnika wzrostu (IGF-1), podstawową prolaktynę (PRL) i po teście z metoklopramidem (PRL/MCP) radioimmunologicznie czterokrotnie: przed leczeniem oraz po 1. 3. i 12. miesiącu leczenia. Gęstość mineralną trzonów kręgów lędźwiowych L2 –L4 badano przed leczeniem i po 12 miesiącach leczenia densytometrem, firmy Luna (DPX-1Q), metodą DEXA. U kobiet z grupy I otrzymującej doustnie fluor i przezskórnie HTZ wystąpił znamienny wzrost stężenia IGF-1, znamienne obniżenie OC, PLCP po 3 i 12 miesiącach leczenia oraz brak statystycznych zmian w stężeniu prolaktyny. Natomiast u kobiet z grupy II otrzymującej w postaci tabletek doustnie fluor i hormonoterapię wspomaganą HTW wystąpiło znamienne obniżenie stężeń IGF-1, OC po 3 i 12 miesiącach leczenia oraz znamienny wzrost stężenia prolaktyny podstawowej i po teście z metoklopramidem po 1. 3. i 12. miesiącu leczenia w porównaniu z wartościami wstępnymi. Stężenia prokolagenu w czasie stosowania doustnie fluoru i HTW nie wykazywały znamiennych różnic. Gęstość mineralna L2-L4 wykazywała znamienne przyrosty u kobiet z grupy I. Natomiast u kobiet z grupy II gęstość mineralna L1, L2 nie wykazywała przyrostu znamiennego, a w kręgu L3, L4 występował znamienny przyrost w porównaniu z wartościami wyjściowymi (p < 0,01).
5
Lobular neoplasia found on breast biopsy: marker of increased risk of malignancy or direct pre-cancerous lesion?
84%
Szynglarewicz B. , Matkowski R. , Halon A. , Kasprzak P. , Forgacz J. , Gisterek I. , Kornafel J.
Folia Histochemica et Cytobiologica
|
2011
|
tom 49
|
nr 3
6
Content available remote Effects of fluoxetine and melatonin on mood, sleep quality and body mass index in postmenopausal women
84%
Chojnacki C. , Walecka-Kapica E. , Klupinska G. , Pawlowicz M. , Blonska A. , Chojnacki J.
Journal of Physiology and Pharmacology
|
2015
|
tom 66
|
nr 5
7
Content available remote Increased number of endothelial progenitors in peripheral blood as a possible early marker of tumour growth in post-menopausal breast cancer patients
84%
Rhone P. , Ruszkowska-Ciastek B. , Celmer M. , Brkic A. , Bielawski K. , Boinska J. , Zarychta E. , Rosc D.
Journal of Physiology and Pharmacology
|
2017
|
tom 68
|
nr 1
8
Content available Psychosocial conditioning of depressive disorders in post-menopausal women
84%
Humeniuk E. , Bojar I. , Owoc A. , Wojtyla A. , Fronczak A.
Annals of Agricultural and Environmental Medicine
|
2011
|
tom 18
|
nr 2
9
The presence and role of progesterone receptor in the ovaries of postmenopausal women who have not applied hormone replacement therapy
84%
Starczewski A. , Brodowska A. , Laszczynska M. , Piasecka M.
|
|
tom 46
|
nr 3
277-282
10
Role of interleukin-6 on RANKL-RANK/osteoprotegerin system in hypothyroid ovariectomized mice
67%
Mysliwiec J. , Zbucki R. , Nikolajuk A. , Mysliwiec P. , Taranta A. , Kaminski K. , Bondyra Z. , Dadan J. , Gorska M. , Winnicka M.
Folia Histochemica et Cytobiologica
|
2010
|
tom 48
|
nr 4
11
Prevalence of estrogen receptor alpha PvuII and XbaI polymorphism in population of Polish postmenopausal women
67%
Jakimiuk A. J. , Nowicka M. , Bogusiewicz M. , Adamiak A. , Skorupski P. , Miotla P. , Rechberger T. , Haczynski J.
Folia Histochemica et Cytobiologica
|
2007
|
tom 45
|
nr 4
331-338
12
The influence of an 8-week ergometer training on postmenopausal women in view of their biological age
67%
Pospieszna B. , Rychlewski T. , Michalak E.
Studies in Physical Culture and Tourism
|
2010
|
tom 17
|
nr 1
13
Content available remote Evaluation of urinary 6-hydroxymelatonin sulphate excretion in women at different age with irritable bowel syndrome
67%
Wisniewska-Jarosinska M. , Chojnacki J. , Konturek S. , Brzozowski T. , Smigielski J. , Chojnacki C.
Journal of Physiology and Pharmacology
|
2010
|
tom 61
|
nr 3
295-300
EN
Melatonin (MT) exerts a beneficial action in the treatment of many diseases, among them also in irritable bowel syndrome (IBS). Its secretion decreases with age, particularly, in the postmenopausal period in women. It has not been determined whether these changes can have an impact on the clinical picture of IBS. The study aimed at evaluating the urinary excretion of the main MT metabolite - 6-hydroxymelatonin sulphate (6-HMS) in women at different age with IBS. The investigations were carried out in five groups of 30 women each. Group Ia (the controls) – premenopausal healthy women (20-39 years), group Ib (the controls) – postmenopausal healthy women (46-66 years), group II – women with constipation predominant IBS (IBS-C; 19-42 years), group III – women with diarrhoea predominant IBS (IBS-D; 20-39 years), group IV- women with IBS-C (49-68 years), group V – women with IBS-D (48-69 years). The diagnosis of IBS was based on the Rome III Criteria after excluding other diseases. On the day of the study the patients remained on the same liquid diet (Nutridrink – 3x400 ml) and 1500 ml of still mineral water. 6-HMS concentration in urine was measured by ELISA method applying IBL antibodies (RE-54031, Immunological Laboratories). The results showed that 24-hour urinary 6-HMS excretion in the studied premenopausal women were as follows: group Ia – 15.13±5.83 µg/24 h, group II – 28.85±12.59 µg/24 h (p<0,01), group III – 26.10±11.76 µg/24 h (p<0,01) and in the postmenopausal subjects they were: group Ib – 10.66±3.23 µg/24 h, group IV – 13.73±5.09 µg/24 h ((p=0,02), group V – 21.39±10.88 µg/24 h (p<0,01). In women with IBS-C the obtained results of 24-hour 6-HMS urinary excretion were independent on the intensity of clinical symptoms. On the other hand, in women with IBS-D, both in the group III and V, higher intensity of ailments was accompanied by significantly increased 6-HMS urinary excretion. The results of the study allowed drawing the following conclusions: (1). 24-hour 6-HMS urinary excretion in women with the constipation-predominant (IBS-C) as well as the diarrhoea-predominant IBS (IBS-D) is higher than in healthy persons both in the premenopausal and postmenopausal period. (2). Relatively high 6-HMS urinary excretion in postmenopausal women with IBS-D indicates an adaptive increase in MT secretion from EC in the gut.
14
The localization of estrogen receptor alpha and its function in the ovaries of postmenopausal women
67%
Brodowska A. , Laszczynska M. , Starczewski A. , Karakiewicz B. , Brodowski J.
Folia Histochemica et Cytobiologica
|
2007
|
tom 45
|
nr 4
325-330
15
Autonomic regulation of gastric myoelectrical activity in postmenopausal women supplemented with ovarian hormones
67%
Banach T. , Thor P. J. , Milewicz T. , Krzysiek J.
Journal of Physiology and Pharmacology. Supplement
|
2001
|
tom 52
|
nr 2
16
Content available The effects of male gender and female sex hormone deficiency on the vascular responses of the rat in vitro
59%
Nevala R. , Paakkari I. , Tarkkila L. , Vapaatalo H.
Journal of Physiology and Pharmacology
|
1996
|
tom 47
|
nr 3
first rewind previous Strona / 1 next fast forward last
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.